Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Ai Lan Cheng"'
Publikováno v:
Chinese Journal of Contemporary Neurology and Neurosurgery, Vol 19, Iss 12, Pp 954-957 (2019)
Objective To analyze the relationship between preoperative enhanced MRI manifestation and recurrent time of recurrent glioblastoma, and to explore the predictive value of imaging signs for recurrence time. Methods A total of 36 patients with patholog
Externí odkaz:
https://doaj.org/article/ac6fbdc1403044859104f4280a1c18e1
Autor:
Ai-Guo Dai, Ai-Lan Cheng, Zhu-Chu Chen, Cen-E Tang, Zhi-Qiang Xiao, Hong Yi, Rui-Cheng Hu, Jian-Ling Li, Shuang-Xiang Tan
Publikováno v:
PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS. 36:1319-1326
Autor:
Shuang-Xiang Tan, Jian-Ling Li, Jun Li, Cen-E Tang, Zhi-Qiang Xiao, Zhu-Chu Chen, Hong Yi, Ai Lan Cheng
Publikováno v:
PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS. 2009:743-749
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 135:1763-1775
In this study, we applied laser capture microdissection and a proteomic approach to identify novel nasopharyngeal carcinoma (NPC) biomarkers.Proteins from pooled microdissected NPC and normal nasopharyngeal epithelial tissues (NNET) were separated by
Autor:
Hong Yi, Yi Sun, Xue-Feng Sun, Zhuchu Chen, Zhi-Qiang Xiao, Gui-Ying Zhang, Huaidong Hu, Feng Ye, Ai-Lan Cheng, Yi-Xuan Yang, Peng Hu
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 135:181-189
To understand the mechanisms of multidrug resistance (MDR) in vincristine-resistant human gastric cancer cell line SGC7901/VCR. Comparative proteomics involving two-dimensional gel electrophoresis (2-DE) and ESI-Q-TOF Mass Spectrometry (MS) was perfo
Autor:
Gu-Qing Zeng, Meixiang Li, Ai-Lan Cheng, Maoyu Li, Lifang Huang, Xing Tan, Li Liao, Yan-Ping Wan, Si-Han Chen
Publikováno v:
Oncology letters. 12(6)
Radiotherapy is the primary treatment for nasopharyngeal carcinoma (NPC), but radioresistance often remains an obstacle to successful treatment. In our previous study, it was demonstrated that Annexin A1 (ANXA1) was involved in the p53-mediated radio
Autor:
Guoqing Li, Gu-Qing Zeng, Meixiang Li, Jie Tang, Ai-Lan Cheng, Zhi-Qiang Xiao, Li Liao, Jia-Quan Qu, Chao Cao
Publikováno v:
Medical Hypotheses. 81:68-70
Radiotherapy is the primary treatment for nasopharyngeal carcinoma (NPC), but radioresistance remains a serious obstacle to successful treatment in many cases. Therefore, the biomarkers for predicting NPC response to radiotherapy are very important f
Publikováno v:
Zhonghua bing li xue za zhi = Chinese journal of pathology. 41(6)
Autor:
Wei-Guo Huang, Maoyu Li, Jian-Ling Li, Cui Li, Zhi-Qiang Xiao, Fang Peng, Peng-Fei Zhang, Zhuchu Chen, Ai-Lan Cheng, Bin Yi, Xin-Hui Li, Hong Yi, Feng Li
Publikováno v:
The international journal of biochemistrycell biology. 42(1)
14-3-3sigma is a potential tumor suppressor, and loss of 14-3-3sigma expression plays an important role in carcinogenesis and metastasis. To explore the possible mechanism of 14-3-3sigma in nasopharyngeal carcinoma (NPC) invasion and metastasis, targ
Autor:
Maoyu Li, Jian-Ling Li, Hong Yi, Can-E Tang, Cui Li, Bin Yi, Zhuchu Chen, Zhi-Qiang Xiao, Shuang-Xiang Tan, Ai-Lan Cheng, Peng-Fei Zhang, Fang Peng, Wei-Guo Huang
Publikováno v:
Journal of cellular biochemistry. 106(5)
14-3-3 sigma, the downstream target of p53, is a negative regulator of cell cycle G2-M phase checkpoint in response to DNA damage. Our previous comparative proteomics study showed that 14-3-3 sigma was downregulated or lost in nasopharyngeal carcinom